Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (1) , 65-71
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Immunotherapy for kidney cancerCurrent Opinion in Urology, 2018
- Systemic Therapy for Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2017
- Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinomaWorld Journal of Urology, 2016
- The biologic effects of cigarette smoke on cancer cellsCancer, 2014
- Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With SunitinibThe Oncologist, 2013
- Smoking negatively impacts renal cell carcinoma overall and cancer‐specific survivalCancer, 2011
- Cigarette Smoking Is Associated With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2011
- Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomyAnnals of Oncology, 2010
- Cancer‐specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989‐2005)Cancer, 2008
- Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the ObviousCancer Epidemiology, Biomarkers & Prevention, 2005